Prevalence of poor cardiac anatomy in carcinoma of the breast treated with whole-breast radiotherapy: Reconciling modern cardiac dosimetry with cardiac mortality data

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 35, Issue 6, 2012, Pages 587-592

  Evans, Suzanne B ^a   Sioshansi, Shirin ^b   Moran, Meena S ^a   Hiatt, Jessica ^c   Price, Lori Lyn ^b   Wazer, David E ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

breast cancer; cardiotoxicity; radiation; statistics

Indexed keywords

DOXORUBICIN; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CARCINOMA; CANCER MORTALITY; CANCER RADIOTHERAPY; CORONARY ARTERY DISEASE; DOSIMETRY; FEMALE; FOLLOW UP; HEART; HEART VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST; BREAST NEOPLASMS; CARCINOMA; CORONARY ARTERY DISEASE; FEMALE; HEART; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGAN SIZE; RADIATION INJURIES; RADIOTHERAPY DOSAGE;

EID: 84870241086     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31822d9cf6     Document Type: Article

References (13)

1. Singletary SE, Connolly JL. Breast cancer staging: Working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin. 2006;56:37-47. (Pubitemid 43228386)
2. Egan RL. Multicentric breast carcinomas: Clinical-radiographicpathologic whole organ studies and 10-year survival. Cancer. 1982;49:1123-1130. (Pubitemid 12187811)
3. Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: Does each focus matter? J Clin Oncol. 2005;23:7497-7502.
4. Andea AA, Wallis T, Newman LA, et al. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer. 2002;94:1383-1390. (Pubitemid 34212630)
5. Holland R, Veling SH, Mravunac M, et al. Histologic multifocality of Tis, T1-2 breast carcinomas: Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979-990. (Pubitemid 15003474)
6. Wilkinson LS, Given-Wilson R, Hall T, et al. Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound. Clin Radiol. 2005;60:573-578. (Pubitemid 40553320)
7. Katz A, Strom EA, Buchholz TA, et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 2001;50: 735-742. (Pubitemid 32515328)
8. Vlastos G, Rubio IT, Mirza NQ, et al. Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer. Ann Surg Oncol. 2000;7:581-587.
9. Oh JL, Dryden MJ, Woodward WA, et al. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol. 2006;24:4971-4975. (Pubitemid 46631398)
10. Fish EB, Chapman JA, Link MA. Assessment of tumor size for multifocal primary breast cancer. Ann Surg Oncol. 1998;5: 442-446. (Pubitemid 28367070)
11. Cabioglu N, Ozmen V, Kaya H, et al. Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg. 2009;208:67-74.
12. Rakowsky E, Klein B, Kahan E, et al. Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat. 1992;21: 121-131.
13. Yerushalmi R, Kennecke H, Woods R, et al. Does multicentric/ multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat. 2009;117:365-370.